A Cost-Effective and Labor-Saving Method for Detecting Human Leukocyte Antigen B27 Status Via Sequence-Encoded Fluorescence Ampli Fi Cation Assay

Nan Sheng,Li Zhao,Shuyun Pang,Wenwen Wang,Panfeng Feng,Jing Zhao,Xiaoxiang Chen,Yingying Gao
DOI: https://doi.org/10.1016/j.jmoldx.2024.03.010
IF: 5.341
2024-01-01
Journal of Molecular Diagnostics
Abstract:Identi fi cation of human leukocyte antigen B27 (HLA-B27) by fl ow cytometry (FCM) has been widely applied in clinical practice for auxiliary diagnosis of ankylosing spondylitis (AS). However, FCM requires freshly prepared samples and relies on expensive equipment, reagents, and an experienced operator. To provide a cheaper and more convenient method for HLA-B27 detection, we proposed a new method termed sequence -encoded fl uorescence ampli fi cation assay (SEFA), which specially recognized sequences of HLA-B27 gene ( HLA-B*27 ) covering current common subtypes in a single closed tube. SEFA could detect as low as 10 pg (equal to 3 copies) genomic DNA per reaction and distinguish HLA-B*27 from other HLA-B alleles with highly similar sequences. A total of 288 clinical samples were tested by SEFA, including 181 patients with AS and 107 healthy controls. Compared with the detection results from FCM, two controversial samples of patients with AS were obtained and further con fi rmed to be consistent with SEFA by Sanger sequencing, indicating that this method was more accurate than FCM. Moreover, SEFA could detect HLA-B27 status by using supernatant from crude extract of 10- m L blood without commercial reagents. Overall, SEFA has the potential to be an alternative for HLA-B27 identi fi cation with the advantage of convenience and low cost, especially suitable for early diagnosis of AS in areas with limited medical resources.
What problem does this paper attempt to address?